Structural and functional changes of the heart in chronic heart failure with preserved left ventricular ejection fraction with excess body weight depending on the presence and form of atrial fibrillation
DOI:
https://doi.org/10.14739/2310-1210.2021.4.232568Keywords:
heart remodeling, chronic heart failure, preserved ejection fraction, excess body weight, atrial fibrillationAbstract
The aim. To examine the features of structural and functional changes of the heart in patients with chronic heart failure with preserved left ventricular ejection fraction (CHF pr EF) with excess body weight depending on the presence and form of atrial fibrillation (AF).
Materials and methods. The study involved 248 patients with CHF pr EF and excess body weight, the mean age was 65.0 ± 11.0 years, 146 females (58.9 %) and 102 males (41.1 %). The first group included 181 patients without concomitant AF, the mean age was 64.0 ± 11.0 years, 110 females (60.8 %) and 71 males (39.2 %); the second group included 67 patients with AF, the mean age was 67.9 ± 11.3 years, 36 females (53.7 %) and 31 males (46.3 %). Subjects with AF were further divided into subgroups: 7 patients with paroxysmal AF, the mean age – 6.7 ± 10.4 years, 3 females (42.9 %) and 4 males (57.1 %), 12 patients with persistent AF, the mean age – 70.8 ± 10.3 years, 10 females (83.3 %) and 2 males (16.7 %); 48 patients with permanent AF, the mean age – 67.3 ± 11.7 years, 23 females (47.9 %) and 25 males (52.1 %).
Results. Patients with concomitant AF had a significantly larger aorta diameter (by 3.0 %), systolic left atrium size (LAs) (by 14.5 %), right atrium size (RA) (by 8.3 %), left ventricle end-diastolic size (LVEDS) (by 7.1 %), left ventricle end-systolic size (LVESS) (by 10.6 %), right ventricle size (RV) (by 13,1 %), mean pulmonary artery pressure (by 20.0 %) and the prevalence of LV eccentric hypertrophy (by 21.0 %; P ˂ 0.001). At the same time, LV wall relative thickness (LV RT) was lower by 6.3 %, LV EF – by 3.4 % and the frequency of LV concentric hypertrophy – by 19.1 % (P ˂ 0.001). In permanent form of AF compared to paroxysmal one, significantly larger LAs (by 10.6 %), RA (by 10.9 %), LV myocardial mass (LV MM) (by 18.1 %) and LV MM index (by 21.1 %) were determined and in contrast to persistent AF, LAs (by 9.8 %), RA (by 11.4 %), LVEDS (by 15.6 %), LVESS (by 15.8 %), RV (by 27, 9 %), LV MM (by 29.8 %), LV MMI (by 14.9 %) were predominant, at the same, LVRT was 12.8 % less.
Conclusions. In patients with CHF pr EF and excess body weight, concomitant AF is associated with greater dilatation of the heart cavities, eccentric hypertrophy predominance, decreased LV contractility and pulmonary hypertension. Compared to other forms, permanent AF is characterized by severe structural and functional changes in the heart, maximal manifestations of LV dilatation and hypertrophy.
References
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G. A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J. P., Lettino, M., Lip, G., Pinto, F. J., Thomas, G. N., … ESC Scientific Document Group. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 42(5), 373-498. https://doi.org/10.1093/eurheartj/ehaa612
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J., Coats, A., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., … ESC Scientific Document Group. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37(27), 2129-2200. https://doi.org/10.1093/eurheartj/ehw128
Voronkov, L. H., Amosova, K. M., Dziak, H. V., Zharinov, O. Y., Kovalenko, V. M., Korkushko, O. V., Nesukai, O. H., Sychov, O. S., Rudyk, Yu. S., & Parkhomenko, O. M. (2017). Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti (2017) [Guidelines of the Ukrainian Association of Cardiology for the Diagnosis and Treatment of Chronic Heart Failure (2017)]. Sertseva nedostatnist ta komorbidni stany, (1, dodatok 1), 1-66. [in Ukranian].
Vyas, V., Hunter, R. J., Longhi, M. P., & Finlay, M. C. (2020). Inflammation and adiposity: new frontiers in atrial fibrillation. EP Europace, 22(11), 1609-1618. https://doi.org/10.1093/europace/euaa214
Zhou, M., Wang, H., Chen, J., & Zhao, L. (2020). Epicardial adipose tissue and atrial fibrillation: Possible mechanisms, potential therapies, and future directions. Pacing and Clinical Electrophysiology, 43(1), 133-145. https://doi.org/10.1111/pace.13825
Packer, M. (2019). Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue. Cardiovascular Diabetology, 18(1), Article 121. https://doi.org/10.1186/s12933-019-0927-9
Mahajan, R., Nelson, A., Pathak, R. K., Middeldorp, M. E., Wong, C. X., Twomey, D. J., Carbone, A., Teo, K., Agbaedeng, T., Linz, D., de Groot, J. R., Kalman, J. M., Lau, D. H., & Sanders, P. (2018). Electroanatomical Remodeling of the Atria in Obesity: Impact of Adjacent Epicardial Fat. JACC: Clinical Electrophysiology, 4(12), 1529-1540. https://doi.org/10.1016/j.jacep.2018.08.014
Fenger-Grøn, M., Vinter, N., & Frost, L. (2020). Body mass and atrial fibrillation risk: Status of the epidemiology concerning the influence of fat versus lean body mass. Trends in Cardiovascular Medicine, 30(4), 205-211. https://doi.org/10.1016/j.tcm.2019.05.009
Neefs, J., Boekholdt, S. M., Khaw, K. T., Luben, R., Pfister, R., Wareham, N. J., Meulendijks, E. R., Sanders, P., & de Groot, J. R. (2019). Body mass index and body fat distribution and new-onset atrial fibrillation: Substudy of the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study. Nutrition, Metabolism & Cardiovascular Diseases, 29(7), 692-700. https://doi.org/10.1016/j.numecd.2019.03.005
Asad, Z., Abbas, M., Javed, I., Korantzopoulos, P., & Stavrakis, S. (2018). Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis. Journal of Cardiovascular Electrophysiology, 29(5), 725-732. https://doi.org/10.1111/jce.13458
Pan, Y., Xu, L., Yang, X., Chen, M., & Gao, Y. (2021). The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases. Heart Failure Reviews. https://doi.org/10.1007/s10741-021-10095-9
Grymonprez, M., Capiau, A., De Backer, T. L., Steurbaut, S., Boussery, K., & Lahousse, L. (2021). The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox. Clinical Cardiology, 44(5), 599-608. https://doi.org/10.1002/clc.23593
(2020). Correction to: Outcomes of Atrial Fibrillation Ablation in Morbidly Obese Patients Following Bariatric Surgery Compared With a Nonobese Cohort. Circulation: Arrhythmia and Electrophysiology, 13(2), Article e000047. https://doi.org/10.1161/HAE.0000000000000047
Baek, Y. S., Yang, P. S., Kim, T. H., Uhm, J. S., Park, J., Pak, H. N., Lee, M. H., & Joung, B. (2017). Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population. Journal of the American Heart Association, 6(6), Article e004705. https://doi.org/10.1161/JAHA.116.004705
Santhanakrishnan, R., Wang, N., Larson, M. G., Magnani, J. W., McManus, D. D., Lubitz, S. A., Ellinor, P. T., Cheng, S., Vasan, R. S., Lee, D. S., Wang, T. J., Levy, D., Benjamin, E. J., & Ho, J. E. (2016). Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation, 133(5), 484-492. https://doi.org/10.1161/CIRCULATIONAHA.115.018614
Dong, Z., Du, X., Lu, S., Jiang, C., Xia, S., He, L., Su, X., Jia, Z., Long, D., Sang, C., Tang, R., Liu, N., Bai, R., Yu, R., Dong, J., & Ma, C. (2021). Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study. BMC Cardiovascular Disorders, 21(1), Article 146. https://doi.org/10.1186/s12872-021-01951-5
Yazaki, K., Ejima, K., Kataoka, S., Higuchi, S., Kanai, M., Yagishita, D., Shoda, M., & Hagiwara, N. (2020). Prognostic Significance of Post-Procedural Left Ventricular Ejection Fraction Following Atrial Fibrillation Ablation in Patients With Systolic Dysfunction. Circulation Reports, 2(12), 707-714. https://doi.org/10.1253/circrep.CR-20-0111
Rayner, J. J., Abdesselam, I., d'Arcy, J., Myerson, S. G., Neubauer, S., Watkins, H., Ferreira, V. M., & Rider, O. J. (2020). Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy. Cardiovascular Diagnosis & Therapy, 10(3), 559-567. https://doi.org/10.21037/cdt-19-587
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
